Graduate Group in Genomics and Computational Biology

Selected Publications

Danjou F, Anni F, Fortina P, Perseu L, Satta S, Dessi C, Lai ME, Devoto M, Galanello R: : Genetic modifiers of beta-thalassemia and clinical severity as assessed by age at first transfusion. Haematologica 97: 989-993, 2012.

Diskin S, Capasso M, Schnepp R, Cole K, Attiyeh E, Hou C, Diamond M, Carpenter E, Winter C, Lee H, Jagannathan J, Latorre V, Iolascon A, Hakonarson H, Devoto M, Maris J: Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma. Nature Genetics 2012.

Goldenberg PC, Calkins ME, Richard J, McDonald-McGinn D, Zackai E, Mitra N, Emanuel B, Devoto M, Borgmann-Winter K, Kohler C, Conroy CG, Gur R, Gur R: Computerized neurocognitive profile in young people with 22q11.2 deletion syndrome compared to youths with schizophrenia and at-risk for psychosis. Am J Med Genet B Neuropsychiatr Genet 1598: 67-93, 2012.

Latorre V, Diskin S, Diamond M, Zhang H, Hakonarson H, Maris J, Devoto M: Replication of neuroblastoma SNP association at the BARD1 locus in African-Americans. Cancer Epidemiol Biomarkers Prev 21: 658-663, 2012.

Bosse K, Diskin S, Cole K, Wood A, Schnepp R, Norris G, Jagannathan J, Laquaglia M, Winter C, Diamond M, Hou C, Attiyeh E, Mosse Y, Dizin E, Zhang Y, Asgharzadeh S, Seeger R, Capasso M, Pawel B, Devoto M, Hakonarson H, Rappaport E, Irminger-Finger I, Maris J: Common variation at BARD1 results in the expression of an oncogenic isoform that influences neuroblastoma susceptibility and tumorigenicity. Cancer Research 72: 2068-2078, 2012.

Nguyen L, Diskin S, Capasso M, Wang K, Diamond M, Glessner J, Kim C, Attiyeh E, Mosse Y, Cole K, Iolascon A, Devoto M, Hakonarson H, Li H, Maris J: Phenotype restricted genome-wide association study using a gene-centric approach identifies three low-risk neuroblastoma susceptibility loci. PLoS Genetics 7: e1002026, 2011.

Wang K, Diskin SJ, Zhang H, Attiyeh EF, Winter C, Hou C, Schnepp RW, Diamond M, Bosse K, Mayes PA, Glessner J, Kim C, Frackelton E, Garris M, Wang Q, Glaberson W, Chiavacci R, Nguyen L, Jagannathan J, Saeki N, Sasaki H, Grant SFA, Iolascon A, Mosse YP, Cole KA, Li H, Devoto M, McGrady PW, London WB, Capasso M, Rahman N, Hakonarson H, Maris JM: Integrative genomics identifies LMO1 as a neuroblastoma oncogene. Nature 469: 216-220, 2011.

Elia J, Glessner J, Wang K, Takahashi N, Shtir C, Hadley D, Sleiman P, Zhang H, Kim C, Robison R, Lyon G, Flory J, Bradfield J, Imielinski M, Hou C, Frackelton E, Chiavacci R, Sakurai T, Rabin C, Middleton F, Thomas K, Garris M, Mentch F, Freitag C, Steinhausen H, Todorov A, Reif A, Rothenberger A, Franke B, Mick E, Roeyers H, Buitelaar J, Lesch K, Banaschewski T, Ebstein R, Mulas F, Oades R, Sergeant J, Sonuga-Barke E, Renner T, Romanos M, Romanos J, Warnke A, Walitza S, Meyer J, Pálmason H, Seitz C, Loo S, Smalley S, Biederman J, Kent L, Asherson P, Anney R, Gaynor J, Shaw P, Devoto M, White P, Grant S, Buxbaum J, Rapoport J, Williams N, Nelson S, Faraone S, Hakonarson, H.: Genome wide copy number variation study associates metabotropic glutamate receptor gene networks with Attention Deficit Hyperactivity Disorder. Nat Genet 44: 78-84, 2011.

Guo T, McDonald McGinn D, Blonska A, Shanske A, Bassett A, Chow E, Bowser M, Sheridan M, Beemer F, Devriendt K, Swillen A, Breckpot J, Digilio MC, Marino B, Dallapiccola B, Carpenter C, Zheng X, Johnson J, Chung J, Higgins AM, Philip N, Simon T, Coleman K, Heine-Suner D, Rosell J, Kates W, Devoto M, Goldmuntz E, Zackai E, Wang T, Shprintzen R, Emanuel B, Morrow B, and the International Chromosome 22q11.2 Consortium: Genotype and cardiovascular phenotype correlations with TBX1 in 1,022 velo-cardiofacial/DiGeorge/22q11.2 deletion syndrome patients. Hum Mutat 32: 1278-1289, 2011.

Devoto M, Specchia C, Laudenslager M, Longo L, Hakonarson H, Maris J, Mossé Y: : Genome-wide linkage analysis to identify genetic modifiers of ALK mutation penetrance in familial neuroblastoma. Hum Hered 71: 135-139, 2011.